Molecular Mechanisms of Insulin Resistance Development

Insulin resistance (IR) is a phenomenon associated with an impaired ability of insulin to stimulate glucose uptake by target cells and to reduce the blood glucose level. A response increase in insulin secretion by the pancreas and hyperinsulinemia are compensatory reactions of the body. The developm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vsevolod Arsen'evich Tkachuk, Alexander Vyacheslavovich Vorotnikov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2014
Materias:
Acceso en línea:https://doaj.org/article/b241062810944dc19909e8bbc4ce26cf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b241062810944dc19909e8bbc4ce26cf
record_format dspace
spelling oai:doaj.org-article:b241062810944dc19909e8bbc4ce26cf2021-11-14T09:00:19ZMolecular Mechanisms of Insulin Resistance Development2072-03512072-037810.14341/DM2014229-40https://doaj.org/article/b241062810944dc19909e8bbc4ce26cf2014-07-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6597https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Insulin resistance (IR) is a phenomenon associated with an impaired ability of insulin to stimulate glucose uptake by target cells and to reduce the blood glucose level. A response increase in insulin secretion by the pancreas and hyperinsulinemia are compensatory reactions of the body. The development of IR leads to the inability of target cells to respond to insulin that results in developing type 2 diabetes mellitus (T2DM) and metabolic syndrome. For this reason, the metabolic syndrome is defined in practice as a combination of IR with one or more pathologies such as T2DM, arterial hypertension, dyslipidemia, abdominal obesity, non-alcoholic fatty liver disease, and some others. However, a combination of high blood glucose and insulin levels always serves as its physiological criterion. IR should be considered as a systemic failure of the endocrine regulation in the body. Physiological causes of IR are diverse. The main ones are nutritional overload and accumulation of certain lipids and their metabolites in cells, low physical activity, chronic inflammation and stress of various nature, including oxidative and endoplasmic reticulum stress (impairment of damaged protein degradation in the cell). Recent studies have demonstrated that these physiological mechanisms likely act through a single intracellular scenario. This is the impairment of signal transduction from the insulin receptor to its targets via the negative feedback mechanism in intracellular insulin-dependent signaling cascades. This review describes the physiological and intracellular mechanisms of insulin action and focuses on their abnormalities upon IR development. Finally, feasible trends in early molecular diagnosis and therapy of IR are discussed.Vsevolod Arsen'evich TkachukAlexander Vyacheslavovich VorotnikovEndocrinology Research Centrearticleinsulin resistancetype 2 diabetes mellitusinsulin-dependent intracellular signalingfeedbackirs proteinphosphor?ylationNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 17, Iss 2, Pp 29-40 (2014)
institution DOAJ
collection DOAJ
language EN
RU
topic insulin resistance
type 2 diabetes mellitus
insulin-dependent intracellular signaling
feedback
irs protein
phosphor?ylation
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle insulin resistance
type 2 diabetes mellitus
insulin-dependent intracellular signaling
feedback
irs protein
phosphor?ylation
Nutritional diseases. Deficiency diseases
RC620-627
Vsevolod Arsen'evich Tkachuk
Alexander Vyacheslavovich Vorotnikov
Molecular Mechanisms of Insulin Resistance Development
description Insulin resistance (IR) is a phenomenon associated with an impaired ability of insulin to stimulate glucose uptake by target cells and to reduce the blood glucose level. A response increase in insulin secretion by the pancreas and hyperinsulinemia are compensatory reactions of the body. The development of IR leads to the inability of target cells to respond to insulin that results in developing type 2 diabetes mellitus (T2DM) and metabolic syndrome. For this reason, the metabolic syndrome is defined in practice as a combination of IR with one or more pathologies such as T2DM, arterial hypertension, dyslipidemia, abdominal obesity, non-alcoholic fatty liver disease, and some others. However, a combination of high blood glucose and insulin levels always serves as its physiological criterion. IR should be considered as a systemic failure of the endocrine regulation in the body. Physiological causes of IR are diverse. The main ones are nutritional overload and accumulation of certain lipids and their metabolites in cells, low physical activity, chronic inflammation and stress of various nature, including oxidative and endoplasmic reticulum stress (impairment of damaged protein degradation in the cell). Recent studies have demonstrated that these physiological mechanisms likely act through a single intracellular scenario. This is the impairment of signal transduction from the insulin receptor to its targets via the negative feedback mechanism in intracellular insulin-dependent signaling cascades. This review describes the physiological and intracellular mechanisms of insulin action and focuses on their abnormalities upon IR development. Finally, feasible trends in early molecular diagnosis and therapy of IR are discussed.
format article
author Vsevolod Arsen'evich Tkachuk
Alexander Vyacheslavovich Vorotnikov
author_facet Vsevolod Arsen'evich Tkachuk
Alexander Vyacheslavovich Vorotnikov
author_sort Vsevolod Arsen'evich Tkachuk
title Molecular Mechanisms of Insulin Resistance Development
title_short Molecular Mechanisms of Insulin Resistance Development
title_full Molecular Mechanisms of Insulin Resistance Development
title_fullStr Molecular Mechanisms of Insulin Resistance Development
title_full_unstemmed Molecular Mechanisms of Insulin Resistance Development
title_sort molecular mechanisms of insulin resistance development
publisher Endocrinology Research Centre
publishDate 2014
url https://doaj.org/article/b241062810944dc19909e8bbc4ce26cf
work_keys_str_mv AT vsevolodarsenevichtkachuk molecularmechanismsofinsulinresistancedevelopment
AT alexandervyacheslavovichvorotnikov molecularmechanismsofinsulinresistancedevelopment
_version_ 1718429551316434944